check_circleStudy Completed

Therapeutic Equivalency, Postmenopause, Hormone Replacement Therapy

Bayer Identifier:

91121

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

EU CT Number:

Not Available
Study to demonstrate bioequivalence after single oral administration of the two different Estradiol Valerate-containing preparations in postmenopausal women

Trial purpose

Please see attached Study Results Summary below.

Key Participants Requirements

Sex

N/A

Age

N/A

Trial summary

Enrollment Goal
36
Trial Dates
July 2002 - September 2002
Phase
Phase 1
Could I Receive a placebo
N/A
Products
Estradiol Valerate (EV, DS00124)
Accepts Healthy Volunteer
N/A

Primary Outcome

Secondary Outcome

Trial design

Open-label, randomized, two-way crossover study to demonstrate bioequivalence after single oral administration of the two different estradiol valerate-containing preparations Estradiol 2 mg Jenapharm and Merimono 2 mg in 36 healthy postmenopausal women
Trial Type
Interventional
Intervention Type
N/A
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A

Additional Information

Click here and search for drug information provided by the FDA.Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.Click here to find results for studies related to marketed products.